MedEasy secures $750k to fund chronic patient care in Bangladesh

An astonishing 70% of healthcare expenses are directly out-of-pocket in Bangladesh. This situation is even more daunting for the 30 million individuals grappling with chronic diseases. Enter MedEasy, a startup ready to redefine the healthcare landscape.

• MedEasy: A startup initiated in 2020 with an already robust user base of over 150,000 people.

• Unique Selling Proposition: An integrated platform offering doctor consultations via video calls and prompt home delivery of medications.

• Recent Achievement: Successfully secured a seed funding round amounting to a substantial $750,000.

• Investors: Seedstars International Ventures, Doha Tech Angels (DTA), Startup Bangladesh Limited, Accelerating Asia, nVentures.

• Speed: They boast a delivery speed four times faster than their competitors, backed by an effective inventory management system and a decentralized distribution network.

• Key Focus: Unlike competitors such as Arogga and Banglameds (now a part of Chaldal), MedEasy specifically targets patients with chronic diseases.

The funding will primarily be invested in enhancing their supply chain, technological capabilities, and data management, ensuring quicker delivery of medicines and improved patient health.